Anterogen.Co.,Ltd. (065660.KQ)

KRW 16060.0

(-6.3%)

Total Assets Summary of Anterogen.Co.,Ltd.

Anterogen.Co.,Ltd.'s latest annual total assets in 2023 was 149.43 Billion KRW , up 20.38% from previous year.
Anterogen.Co.,Ltd.'s latest quarterly total assets in 2024 Q2 was 118.38 Billion KRW , down -2.23% from previous quarter.
Anterogen.Co.,Ltd. reported annual total assets of 124.13 Billion KRW in 2022, down -9.19% from previous year.
Anterogen.Co.,Ltd. reported annual total assets of 136.7 Billion KRW in 2021, up 45.11% from previous year.
Anterogen.Co.,Ltd. reported quarterly total assets of 118.38 Billion KRW for 2024 Q2, down -2.23% from previous quarter.
Anterogen.Co.,Ltd. reported quarterly total assets of 133.52 Billion KRW for 2023 Q2, up 3.25% from previous quarter.

Annual Total Assets Chart of Anterogen.Co.,Ltd. (2023 - 2015)

Historical Annual Total Assets of Anterogen.Co.,Ltd. (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	149.43 Billion KRW	20.38%
2022	124.13 Billion KRW	-9.19%
2021	136.7 Billion KRW	45.11%
2020	94.2 Billion KRW	11.36%
2019	84.59 Billion KRW	-16.61%
2018	101.44 Billion KRW	74.49%
2017	58.13 Billion KRW	64.1%
2016	35.42 Billion KRW	91.63%
2015	18.48 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	121.09 Billion KRW	-18.96%
2024 Q2	118.38 Billion KRW	-2.23%
2023 Q2	133.52 Billion KRW	3.25%
2023 Q4	149.43 Billion KRW	-6.5%
2023 FY	149.43 Billion KRW	20.38%
2023 Q1	129.32 Billion KRW	4.18%
2023 Q3	159.82 Billion KRW	19.7%
2022 FY	124.13 Billion KRW	-9.19%
2022 Q4	124.13 Billion KRW	-2.39%
2022 Q3	127.17 Billion KRW	-4.33%
2022 Q1	155.09 Billion KRW	13.46%
2022 Q2	132.93 Billion KRW	-14.29%
2021 Q4	136.7 Billion KRW	8.0%
2021 FY	136.7 Billion KRW	45.11%
2021 Q3	126.57 Billion KRW	5.79%
2021 Q1	115.19 Billion KRW	22.28%
2021 Q2	119.64 Billion KRW	3.86%
2020 Q2	95.77 Billion KRW	16.32%
2020 Q3	96.19 Billion KRW	0.44%
2020 Q4	94.2 Billion KRW	-2.07%
2020 FY	94.2 Billion KRW	11.36%
2020 Q1	82.33 Billion KRW	-2.67%
2019 Q3	85.57 Billion KRW	-10.4%
2019 Q2	95.51 Billion KRW	-20.32%
2019 Q1	119.87 Billion KRW	18.17%
2019 FY	84.59 Billion KRW	-16.61%
2019 Q4	84.59 Billion KRW	-1.15%
2018 Q3	93.54 Billion KRW	-0.66%
2018 Q4	101.44 Billion KRW	8.44%
2018 FY	101.44 Billion KRW	74.49%
2018 Q1	60.04 Billion KRW	3.29%
2018 Q2	94.16 Billion KRW	56.83%
2017 Q3	58.18 Billion KRW	23.78%
2017 Q1	36.14 Billion KRW	2.01%
2017 Q2	47 Billion KRW	30.06%
2017 Q4	58.13 Billion KRW	-0.08%
2017 FY	58.13 Billion KRW	64.1%
2016 FY	35.42 Billion KRW	91.63%
2016 Q1	36.16 Billion KRW	95.6%
2016 Q2	35.72 Billion KRW	-1.21%
2016 Q4	35.42 Billion KRW	-0.35%
2016 Q3	35.55 Billion KRW	-0.48%
2015 Q4	18.48 Billion KRW	0.0%
2015 FY	18.48 Billion KRW	0.0%

Peer Total Assets Comparison of Anterogen.Co.,Ltd.

Name	Total Assets	Total Assets Difference
HLB Co., Ltd.	751.72 Billion KRW	80.121%
iNtRON Biotechnology, Inc.	98.61 Billion KRW	-51.531%
BINEX Co., Ltd.	257.01 Billion KRW	41.858%
Bioneer Corporation	315.48 Billion KRW	52.635%
MEDIPOST Co., Ltd.	449.39 Billion KRW	66.748%
CrystalGenomics, Inc.	243.11 Billion USD	38.535%
Helixmith Co., Ltd	227.27 Billion KRW	34.252%
Chabiotech Co.,Ltd.	1725.57 Billion KRW	91.34%
Medy-Tox Inc.	611.62 Billion KRW	75.568%
Peptron, Inc.	52.49 Billion KRW	-184.654%
Amicogen, Inc.	467.09 Billion KRW	68.008%
Genexine, Inc.	376.58 Billion KRW	60.319%
HLB Therapeutics Co.,Ltd.	200.79 Billion KRW	25.58%
LegoChem Biosciences, Inc.	189.5 Billion KRW	21.145%
ALTEOGEN Inc.	256.09 Billion KRW	41.651%
PharmaResearch Co., Ltd.	535.28 Billion KRW	72.084%
SillaJen, Inc.	76.71 Billion KRW	-94.788%
JETEMA, Co., Ltd.	252.14 Billion KRW	40.736%
OliX Pharmaceuticals,Inc	102.82 Billion KRW	-45.326%
Genomictree Inc.	132.84 Billion KRW	-12.487%
MedPacto, Inc.	80.47 Billion KRW	-85.688%
D&D Pharmatech	79.2 Billion KRW	-88.668%
EASY BIO,Inc.	172.04 Billion KRW	13.142%
GI Innovation, Inc.	81.34 Billion KRW	-83.712%